Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY)

Clinical trial NCT05165433 · COMPLETED

Trial details

NCT number: NCT05165433
Sponsor: Akamis Bio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Tumor Metastatic Cancer

Start date: 2022-04-13
Primary completion: 2025-08-29
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.